|
PEAK CONCENTRATION & ABSORPTION OF RALOXIFENE IS REDUCED BY 28% & 14% RESPECTIVELY, BUT SYSTEMIC EXPOSURE & ELIMEINATION RATE WERE NOT AFFECTED
|
CHLOROQUINE REDUCES GASTRIC ABSORPTION OF THE DRUG
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
ALLUPURINOL & BACAMPICILLIN CONCURRENT ADMINISTRATION SUBSTANTIALLY INCREASE THE INCIDENCE OF RASHES IN PATIENTS RECIEVING BOTH DRUGS AS COMPARED TO PATIENTS RECIEVING AMPICILLIN ALONE
|
CO-ADMINISTRATION OF ALLOPURINOL AND AMPICILLIN INCREASES SUBSTANTIALLY THE INCIDENCE OF RASHES
|
DECREASES THE RENAL TUBULAR SECRETION OF AMPICILLIN AND SULBACTAM ; CO-ADMINISTRATION OF PROBENECID WITH UNASYN MAY RESULT IN INCREASED AND PROLONGED BLOOD LEVELS OF AMPICILLIN AND SULBACTAM
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
MAY REDUCE THE RENAL CLEARANCE OF METHOTREXATE ; ELEVATES SERUM METHOTREXATE CONCENTRATIONS RESULTING IN SEVERE HEMATOLOGICAL AND GASTROINTESTINAL TOXICITY
|